Status:
COMPLETED
A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Prostate Cancer
Eligibility:
MALE
20+ years
Phase:
PHASE1
Brief Summary
The purpose of this clinical study is to assess the safety and tolerability of BMS-641988 once daily orally in Japanese patients with castration resistant prostate cancer
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with castration-resistant prostate cancer and serum testosterone ≤50 ng/dL progressive to current therapy who satisfy the inclusion and exclusion criteria
Exclusion
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00644488
Start Date
July 1 2008
End Date
March 1 2009
Last Update
January 25 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Hidaka, Saitama, Japan, 3501298
2
Local Institution
Hamamatsu, Shizuoka, Japan, 431-3192
3
Local Institution
Koto-Ku, Tokyo, Japan, 1358550